Wall Street Experts
ver. ZuMIgo(08/25)
Collegium Pharmaceutical, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 599
EBIT TTM (mln): 199
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
Rok finansowy |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
2 |
28 |
280 |
297 |
310 |
277 |
464 |
567 |
631 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
inf% |
1564.3% |
884.7% |
5.8% |
4.5% |
-10.7% |
67.6% |
22.2% |
11.4% |
Marża brutto |
0.0% |
0.0% |
0.0% |
87.6% |
90.9% |
40.9% |
34.7% |
58.0% |
54.4% |
45.2% |
57.5% |
59.8% |
EBIT (mln) |
-16 |
-18 |
-27 |
-94 |
-75 |
-21 |
-24 |
-5 |
-47 |
-105 |
167 |
170 |
EBIT Δ r/r |
0.0% |
10.1% |
52.3% |
249.7% |
-19.8% |
-72.6% |
14.8% |
-78.6% |
818.2% |
123.9% |
-259.7% |
1.8% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
-5498.7% |
-264.9% |
-7.4% |
-8.0% |
-1.6% |
-16.9% |
-22.5% |
29.5% |
26.9% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
1 |
20 |
1 |
29 |
21 |
63 |
83 |
74 |
EBITDA (mln) |
-16 |
-17 |
-27 |
-94 |
-75 |
-19 |
-22 |
56 |
22 |
34 |
332 |
170 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
-5498.7% |
-262.9% |
-6.8% |
-7.4% |
18.2% |
8.0% |
7.4% |
58.5% |
26.9% |
Podatek (mln) |
0 |
0 |
-0 |
0 |
-1 |
-111 |
-15 |
1 |
-75 |
-4 |
28 |
29 |
Zysk Netto (mln) |
-16 |
-18 |
-27 |
-94 |
-75 |
-39 |
-8 |
27 |
72 |
-25 |
48 |
69 |
Zysk netto Δ r/r |
0.0% |
10.6% |
52.1% |
245.5% |
-20.5% |
-47.7% |
-79.2% |
-428.3% |
167.3% |
-135.0% |
-292.6% |
43.7% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
-5504.1% |
-262.9% |
-14.0% |
-2.7% |
8.6% |
25.8% |
-5.4% |
8.5% |
11.0% |
EPS |
-2.17 |
-2.4 |
-2.01 |
-3.88 |
-2.47 |
-1.19 |
-0.24 |
0.78 |
2.05 |
-0.74 |
1.43 |
2.14 |
EPS (rozwodnione) |
-2.17 |
-2.4 |
-2.01 |
-3.88 |
-2.47 |
-1.19 |
-0.24 |
0.76 |
1.86 |
-0.74 |
1.29 |
1.71 |
Ilośc akcji (mln) |
7 |
7 |
14 |
24 |
30 |
33 |
33 |
34 |
35 |
34 |
34 |
32 |
Ważona ilośc akcji (mln) |
7 |
7 |
14 |
24 |
30 |
33 |
33 |
35 |
41 |
34 |
42 |
40 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |